التصنيف: anti-diabetic.secretagogues.dpp-4 inhibitors المادة الفعالة:linagliptin+metformin
this is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults: as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance or contraindica
